Society For Translational Oncology Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2019 | 389,120 | 349,503 | 39,617 | 20.3 | 21% |
| 2020 | 285,145 | 194,327 | 90,818 | 42.0 | 13% |
| 2021 | 1,176,418 | 554,292 | 622,126 | 28.0 | 7% |
| 2022 | 1,410,812 | 885,287 | 525,525 | 23.0 | 15% |
| 2023 | 467,002 | 722,531 | −255,529 | 23.4 | 19% |
In its most recent public year (2023), this organization spent $255,529 more than it brought in. Its reserves stood at about 23.4 months of spending, up from 20.3 in 2019. Staff pay was 19% of spending. $1,002,291 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works